Health Trials

Calcium Administration in Life-saving Management During Massive Hemorrhage

ConditionsMassive HemorrhageTraumaHypocalcemia
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

This study evaluates the feasibility of conducting a larger study on the impact of treating massive hemorrhage with calcium in trauma patients. Patients undergoing the Massive Hemorrhage Protocol (MHP) will be randomly assigned to receive either calcium gluconate or placebo drug after every 4 packs of units of RBCs received during the MHP.

Eligibility criteria

Qualifiers

Adult trauma patients undergoing the MHP at Victoria Hospital, London, Ontario

Disqualifiers

Under the age of 18

Pregnant

Trial design

Treatments tested in this trial

  • calcium gluconate
  • Control: Placebo

Treatment groups

81 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

London Health Sciences Centre

Sponsor institution

Source ClinicalTrials.gov